Multivariate prognostic model for patients with thick cutaneous melanoma: Importance of sentinel lymph node status

被引:96
作者
Ferrone, CR
Panageas, KS
Busam, K
Brady, MS
Coit, DG
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA
关键词
thick cutaneous melanoma; sentinel lymph node; prognostic model; recurrence;
D O I
10.1007/BF02574479
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The overall prognosis of patients with thick cutaneous melanoma (TCM) is generally thought to be poor. Surgically staging these patients with sentinel lymph node (SLN) biopsy remains controversial. This study was performed to determine whether SLN status improved our ability to predict outcome over other known prognostic factors and to develop a model incorporating independent prognostic factors to estimate the risk of recurrence for an individual patient. Methods: A prospective database identified patients with TCM (>4.0 mm or Clark level V) and clinically negative nodes who underwent SLN biopsy. Univariate and multivariate analyses were performed. Results: From 1991 to 2001, 126 patients were identified; 75 (60%) were male. The median age was 60 years. The median tumor thickness was 5.5 mm, and 43% were ulcerated. Thirty percent of patients had a positive SLN. Recurrence was seen in 50 patients (40%). Median follow-up, relapse-free survival, and overall survival were 25, 50, and 68 months, respectively. Factors independently predictive of recurrence were age 60 years, depth >5.5 mm, ulceration, and SLN positivity. SLN status was the most significant prognostic factor (P<.001). The relative risk of recurrence for an individual patient ranged from 1 in patients for whom no adverse factors were present to 29.4 when all factors were present. Conclusions: SLN status was the strongest independent predictor of outcome in patients with TCM. However, patients with TCM are prognostically heterogeneous, and all independently predictive factors should be considered when an individual patient's risk of recurrence is assessed.
引用
收藏
页码:637 / 645
页数:9
相关论文
共 13 条
[1]  
[Anonymous], 1983, MANUAL STAGING CANC
[2]  
[Anonymous], 1988, Manual for Staging of Cancer
[3]  
[Anonymous], 1992, MANUAL STAGING CANC
[5]   A COMPARISON OF PROGNOSTIC FACTORS AND SURGICAL RESULTS IN 1,786 PATIENTS WITH LOCALIZED (STAGE-1) MELANOMA TREATED IN ALABAMA, USA, AND NEW-SOUTH-WALES, AUSTRALIA [J].
BALCH, CM ;
SOONG, SJ ;
MILTON, GW ;
SHAW, HM ;
MCGOVERN, VJ ;
MURAD, TM ;
MCCARTHY, WH ;
MADDOX, WA .
ANNALS OF SURGERY, 1982, 196 (06) :677-684
[6]   Prognostic factors analysis of 17,600 melanoma patients: Validation of the American Joint Committee on Cancer melanoma staging system [J].
Balch, CM ;
Soong, SJ ;
Gershenwald, JE ;
Thompson, JF ;
Reintgen, DS ;
Cascinelli, N ;
Urist, M ;
McMasters, KM ;
Ross, MI ;
Kirkwood, JM ;
Atkins, MB ;
Thompson, JA ;
Coit, DG ;
Byrd, D ;
Desmond, R ;
Zhang, YT ;
Liu, PY ;
Lyman, GH ;
Morabito, A .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (16) :3622-3634
[7]   Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma [J].
Balch, CM ;
Buzaid, AC ;
Soong, SJ ;
Atkins, MB ;
Cascinelli, N ;
Coit, DG ;
Fleming, ID ;
Gershenwald, JE ;
Houghton, A ;
Kirkwood, JM ;
McMasters, KM ;
Mihm, MF ;
Morton, DL ;
Reintgen, DS ;
Ross, MI ;
Sober, A ;
Thompson, JA ;
Thompson, JF .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (16) :3635-3648
[8]  
COIT D, 1990, ARCH SURG-CHICAGO, V125, P322
[9]  
COIT DG, 2002, SENTINEL LYMPH NODE, P135
[10]  
Fleming ID, 1997, MANUAL STAGING CANC